Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: access to ESRD treatments.
about
How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings?Overcoming the Underutilisation of Peritoneal DialysisDisparities in kidney transplant outcomes: a reviewConsidering health insurance: how do dialysis initiates with Medicaid coverage differ from persons without Medicaid coverage?What is the evidence that peritoneal dialysis is underutilized as an ESRD therapy?Spatial distribution of end-stage renal disease (ESRD) and social inequalities in mixed urban and rural areas: a study in the Bretagne administrative region of France.Renal replacement therapy in Ukraine: epidemiology and international comparisons.The EVEREST study: an international collaboration.Global trends in rates of peritoneal dialysisBismarck or Beveridge: a beauty contest between dinosaurs.The impact of rural hospital closures on equity of commuting time for haemodialysis patients: simulation analysis using the capacity-distance modelA cost evaluation of peritoneal dialysis and hemodialysis in the treatment of end-stage renal disease in Sao Paulo, Brazil.The financial impact of immunosuppressant expenses on new kidney transplant recipients.Comparison of direct medical costs between automated and continuous ambulatory peritoneal dialysis.Superior outcomes of kidney transplantation compared with dialysis: An optimal matched analysis of a national population-based cohort study between 2005 and 2008 in Korea.Effect of a rosmarinic acid supplemented hemodialysis fluid on inflammation of human vascular endothelial cellsIncidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance.
P2860
Q26764729-A54F9BAC-D099-40F4-A01E-A0B8C7D763A6Q26774019-68F690AF-1D33-4E2B-BA26-DB3CA16B1755Q33636818-93283C6B-D62C-4FF0-9CD9-CFB76F1484ECQ34021329-D4EC3A93-5AA9-481D-9B01-7E46B8C1CB7BQ34722861-A6B739AF-3390-4319-AC9E-41198BF7618AQ35026499-B6765576-AEE4-4E94-89BB-983FD1C690AFQ35227577-1EF715AB-F82A-4B53-8EDC-883C26D47575Q35574292-44EDC00E-FECE-4E16-B50E-1D24361AD3DAQ35804211-22D0E627-0A80-4A4D-93DF-2C7F385F5260Q35915705-B50C7EA6-619F-4D63-AC84-01FC6B8C7B49Q36416405-BC93FAE6-23DE-419A-94ED-2AB9CA46FF6BQ36831513-00B781AD-10A4-4011-AA70-E3CCC75EBFE8Q36992544-B74E4ACA-1848-4B76-9935-51ADC5F20988Q37389819-E1C1C31A-376A-4E0A-BB85-3DE2BE3E29FFQ37726660-DD49069E-9083-4F25-AA74-125C5C4BD712Q42660367-BB260D98-49DD-42C7-A5F4-204E19947DE3Q43771862-5084B941-3237-4911-BF28-A670CD1F383E
P2860
Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: access to ESRD treatments.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Healthcare systems and end-sta ...... ew: access to ESRD treatments.
@ast
Healthcare systems and end-sta ...... ew: access to ESRD treatments.
@en
type
label
Healthcare systems and end-sta ...... ew: access to ESRD treatments.
@ast
Healthcare systems and end-sta ...... ew: access to ESRD treatments.
@en
prefLabel
Healthcare systems and end-sta ...... ew: access to ESRD treatments.
@ast
Healthcare systems and end-sta ...... ew: access to ESRD treatments.
@en
P2093
P356
P1476
Healthcare systems and end-sta ...... ew: access to ESRD treatments.
@en
P2093
P356
10.1093/NDT/14.SUPPL_6.10
P407
P478
14 Suppl 6
P577
1999-01-01T00:00:00Z